Fortitude Family Office’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$444 Buy
+8
New +$430 ﹤0.01% 1769
2024
Q4
Sell
-31
Closed -$1.04K 1293
2024
Q3
$1.04K Hold
31
﹤0.01% 1099
2024
Q2
$777 Buy
+31
New +$722 ﹤0.01% 898

Other funds holding ANAB

Fortitude Family Office's ANAB Position: Q1 2026 in Review

Fortitude Family Office opened a new position in AnaptysBio (ANAB) in Q1 2026: 8 shares worth $444. The stake represents ﹤0.01% of the portfolio and ranks #1769 among its holdings. This is a return to the name: Fortitude Family Office previously reported a position in ANAB as recently as Q3 2024.

Fortitude Family Office first reported a position in ANAB in Q2 2024 and has held it in 3 quarters since. The position peaked at $1.04K in Q3 2024. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

  • Fortitude Family Office held 8 shares of AnaptysBio worth $444 as of Q1 2026.
  • AnaptysBio was a new Fortitude Family Office position in Q1 2026.
  • AnaptysBio made up ﹤0.01% of Fortitude Family Office's portfolio in Q1 2026, its #1769 holding.
  • Fortitude Family Office first reported a position in AnaptysBio in Q2 2024 and has held it in 3 quarters since.
  • Fortitude Family Office's AnaptysBio position peaked at $1.04K in Q3 2024.
  • 207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Fortitude Family Office's 13F filing for Q1 2026, filed 16 Apr 2026.